April 2, 2021
9:00 am - 12:00 pm
There has been an explosion of research in autism spectrum disorder (ASD) and our understanding of the underlying neurobiology and genetic mechanisms have considerably improved. Over the last few years, there has been an increase in the number of clinical trials evaluating a wide range of interventions for core ASD features and associated behaviors. However there has been limited progress in the identification of effective pharmacological interventions targeting social communication deficits and restricted/repetitive behaviors. In the proposed lectures, the different pharmacological agents used in the treatment of ASD will be reviewed and recent findings from scientific studies will be discussed. Additionally, promising experimental compounds, such as oxytocin and arginine vasopressin, will be examined and available evidence will be analyzed.
Download flyer for full course description and speaker bio.